Inhibitors of human immunodeficiency virus replication

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9663536
APP PUB NO 20160002263A1
SERIAL NO

14769646

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection. Formule (I).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIIV HEALTHCARE UK (NO 5) LIMITED980 GREAT WEST ROAD BRENTFORD MIDDLESEX TW89GS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Naidu, B Narasimhulu Durham, US 77 382
Patel, Manoj Berlin, US 51 188
Peese, Kevin Haddam, US 16 29
Wang, Zhongyu Tolland, US 33 130

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 30, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00